2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1629199096 D.O.
Verify on CMS →

FAYSSAL EL-JABALI, D.O.

Retina Specialist (Ophthalmology) Physician in TAMPA, Florida. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
260
Medicare Part D claims · 73 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
41%
generic claims · 59% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.8891/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$2.0K
28 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

FAYSSAL EL-JABALI, D.O. reported a CMS MIPS final score of 98.8891/100 — above the 83.1 national average — and filed 260 Medicare Part D claims in 2023.

98.8891/100
MIPS score · +16 vs avg
260
Part D claims, 2023
41%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

FAYSSAL EL-JABALI, D.O.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 11% higher than 89% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

FAYSSAL EL-JABALI, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about FAYSSAL EL-JABALI, D.O.?

High performer (top quartile)

NPI registry status

Active

Issued 04/03/2007

NPI 1629199096

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

260 53% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

98.8891/100 15.789100000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Florida

How Retina Specialist (Ophthalmology) Physician compares to other specialties among Florida providers

Florida providers

Retina Specialist (Ophthalmology) Physician share within Florida

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within Florida

Medicare quality performance — MIPS

FAYSSAL EL-JABALI, D.O.'s 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
98.8891/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 98.8891/100 vs national avg 83.1

0%100%National avg83%98.9%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 98.8891/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

FAYSSAL EL-JABALI, D.O. is a Retina Specialist (Ophthalmology) Physician provider practicing in TAMPA, Florida, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1629199096. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

FAYSSAL EL-JABALI, D.O. appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding D.O. credentials at 4178 N ARMENIA AVE, TAMPA, FL, 33607, with a listed phone of (813) 999-3998. NPI 1629199096 was issued on 04/03/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what EL-JABALI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 260 prescription claims written by this provider, covering 73 Medicare beneficiaries and totaling roughly $209K in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.8891/100 for the 2023 performance year (Quality 100, Cost 100), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4178 N ARMENIA AVE
TAMPA, FL 33607

Provider Details

NPI 1629199096
Specialty Retina Specialist (Ophthalmology) Physician
Credentials D.O.
Gender Male
NPI Issued 04/03/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

98.8891
Final Score
Avg: 83.1
100
Quality
100
Cost
89
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where FAYSSAL EL-JABALI, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

EYE ASSOCIATES OF MANATEE, LLP
BRADENTON, FL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for FAYSSAL EL-JABALI, D.O.. Source: openpaymentsdata.cms.gov.

Total received

$2.0K

Largest payer

Regeneron Healthcare Solutions, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Florida FLDOH 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~75K Florida medical licensees in 2023 — they are NOT specific to FAYSSAL EL-JABALI, D.O.. To verify FAYSSAL EL-JABALI, D.O.'s current license status, search the FLDOH public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

480
Total board actions, Florida 2023
Across 467 cases
6.40
Actions per 1,000 licensees
Florida statewide rate
monetary fine
Most common action type
138 cases

FLDOH publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Florida disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

FAYSSAL EL-JABALI, D.O. — brand share 59.0%
Specialty average (est.)

59% brand-name claims vs 41% generic, on 260 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

260
Total Claims
$209K
Total Drug Cost
73
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
329
Total Day Supply
8,421
Brand vs Generic
59% brand / 41% generic
Brand Drug Cost
$202K
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
1.52
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Eylea
Aflibercept
65
Prednisolone Acetate
59
Atropine Sulfate
24
Ofloxacin
17
Difluprednate
14
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
14
Timolol Maleate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How FAYSSAL EL-JABALI, D.O. fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

FAYSSAL EL-JABALI, D.O.'s 260 claims are below the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in Florida

Other clinicians with the same primary specialty enrolled in Florida, drawn from the same CMS NPPES roster as EL-JABALI.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is FAYSSAL EL-JABALI, D.O.'s specialty?
FAYSSAL EL-JABALI, D.O. specializes in Retina Specialist (Ophthalmology) Physician and practices in TAMPA, Florida. Credentials: D.O..
How much does FAYSSAL EL-JABALI, D.O. prescribe under Medicare Part D?
In 2023, FAYSSAL EL-JABALI, D.O. wrote 260 Medicare Part D claims totaling $209K in drug costs for 73 beneficiaries.
What is FAYSSAL EL-JABALI, D.O.'s Medicare quality score?
FAYSSAL EL-JABALI, D.O. has a CMS MIPS Final Score of 98.8891/100 (Quality: 100, Cost: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is FAYSSAL EL-JABALI, D.O. located?
FAYSSAL EL-JABALI, D.O. is located at 4178 N ARMENIA AVE, TAMPA, FL, 33607. Phone: (813) 999-3998.
What is FAYSSAL EL-JABALI, D.O.'s NPI number?
FAYSSAL EL-JABALI, D.O.'s National Provider Identifier (NPI) is 1629199096, issued on 04/03/2007.
Does FAYSSAL EL-JABALI, D.O. prescribe more brand-name or generic drugs?
FAYSSAL EL-JABALI, D.O.'s prescribing is 59% brand-name and 41% generic drugs by claim count, with $202K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does FAYSSAL EL-JABALI, D.O. prescribe most often?
Based on 2023 Medicare Part D data, FAYSSAL EL-JABALI, D.O.'s most frequently prescribed drugs include Eylea, Prednisolone Acetate, Atropine Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does FAYSSAL EL-JABALI, D.O. accept Medicare?
FAYSSAL EL-JABALI, D.O. appears in CMS Medicare data with 260 Part D claims and 73 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify FAYSSAL EL-JABALI, D.O.'s credentials?
FAYSSAL EL-JABALI, D.O.'s NPI is 1629199096 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology